Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy - a Randomized Controlled, Multi-center Trial

NCT05606588 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT05606588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05606588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy - a Randomized Controlled, Multi-center Trial
Lead sponsor
University of Basel
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
March 31, 2026
Enrollment
131 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, pediatric cancer